NASDAQ:BHST BioHarvest Sciences (BHST) Stock Price, News & Analysis $8.40 -0.60 (-6.67%) As of 02:32 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About BioHarvest Sciences Stock (NASDAQ:BHST) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioHarvest Sciences alerts:Sign Up Key Stats Today's Range$8.40▼$8.8450-Day Range$6.65▼$9.6052-Week Range$4.66▼$9.90Volume4,378 shsAverage Volume20,231 shsMarket Capitalization$137.93 millionP/E RatioN/ADividend YieldN/APrice Target$13.67Consensus RatingBuy Company Overview BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada. Read More Receive BHST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHST Stock News HeadlinesDiamond Equity Issues Pessimistic Forecast for BHST EarningsAugust 17, 2025 | americanbankingnews.comBioHarvest Sciences Updates Insider Trading PolicyAugust 15, 2025 | msn.comThis stock could leave NVDA in the dustInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.August 27 at 2:00 AM | InvestorPlace (Ad)BioHarvest Sciences Updates Insider Trading Policy to Enhance Trading WindowAugust 14, 2025 | msn.comBioHarvest Sciences Reports Strong Growth Amid ChallengesAugust 13, 2025 | msn.comBioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call TranscriptAugust 11, 2025 | seekingalpha.comBioHarvest Sciences Inc.: BioHarvest Sciences Reports Second Quarter 2025 Financial ResultsAugust 11, 2025 | finanznachrichten.deBioHarvest Clears Breakeven on Q2 NumbersAugust 11, 2025 | baystreet.caSee More Headlines BHST Stock Analysis - Frequently Asked Questions How have BHST shares performed this year? BioHarvest Sciences' stock was trading at $6.18 on January 1st, 2025. Since then, BHST shares have increased by 35.9% and is now trading at $8.40. How were BioHarvest Sciences' earnings last quarter? BioHarvest Sciences Inc. (NASDAQ:BHST) announced its quarterly earnings data on Monday, August, 11th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.04. The business had revenue of $8.52 million for the quarter, compared to analyst estimates of $8.53 million. BioHarvest Sciences had a negative net margin of 39.95% and a negative trailing twelve-month return on equity of 11,357.84%. Read the conference call transcript. Who are BioHarvest Sciences' major shareholders? Top institutional shareholders of BioHarvest Sciences include Magnus Financial Group LLC (0.43%) and True North Advisors LLC (0.13%). How do I buy shares of BioHarvest Sciences? Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/11/2025Today8/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:BHST Previous SymbolNASDAQ:BHST CIK1723464 Webbioharvest.com Phone646-863-2177FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for BioHarvest Sciences$13.67 High Price Target$15.00 Low Price Target$12.00 Potential Upside/Downside+60.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.70) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.91 million Net Margins-39.95% Pretax Margin-39.67% Return on Equity-11,357.84% Return on Assets-39.94% Debt Debt-to-Equity RatioN/A Current Ratio0.60 Quick Ratio0.36 Sales & Book Value Annual Sales$30.19 million Price / Sales4.63 Cash FlowN/A Price / Cash FlowN/A Book Value($0.26) per share Price / Book-32.73Miscellaneous Outstanding Shares16,425,000Free FloatN/AMarket Cap$139.78 million OptionableN/A Beta0.68 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:BHST) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.